Shi MJ - Search Results

1

High CD3D/CD4 ratio predicts better survival in muscle-invasive bladder cancer.

Shi MJ, Meng XY, Wu QJ, Zhou XH. Shi MJ, et al. Cancer Manag Res. 2019 Apr 12;11:2987-2995. doi: 10.2147/CMAR.S191105. eCollection 2019. Cancer Manag Res. 2019. PMID: 31114346 Free PMC article.

2

Circulating tumor cells in breast cancer and its association with tumor clinicopathological characteristics: a meta-analysis.

Liao Y, Wang SY, Meng XY, Yang J, Shi MJ, Liu HL, Chen FF, Xiong B. Liao Y, et al. Among authors: shi mj. Med Oncol. 2014 Dec;31(12):343. doi: 10.1007/s12032-014-0343-7. Epub 2014 Nov 21. Med Oncol. 2014. PMID: 25412938

3

Sleep duration and risk of all-cause mortality: A flexible, non-linear, meta-regression of 40 prospective cohort studies.

Liu TZ, Xu C, Rota M, Cai H, Zhang C, Shi MJ, Yuan RX, Weng H, Meng XY, Kwong JS, Sun X. Liu TZ, et al. Among authors: shi mj. Sleep Med Rev. 2017 Apr;32:28-36. doi: 10.1016/j.smrv.2016.02.005. Epub 2016 Mar 3. Sleep Med Rev. 2017. PMID: 27067616 Review.

4

Concurrent cisplatin-based chemoradiotherapy versus exclusive radiotherapy in high-risk cervical cancer: a meta-analysis.

Meng XY, Liao Y, Liu XP, Li S, Shi MJ, Zeng XT. Meng XY, et al. Among authors: shi mj. Onco Targets Ther. 2016 Mar 31;9:1875-88. doi: 10.2147/OTT.S97436. eCollection 2016. Onco Targets Ther. 2016. PMID: 27099519 Free PMC article.

5

Association between the TACC3 rs798766 Polymorphism and Risk of Urinary Bladder Cancer: A Synthesis Based on Current Evidence.

Meng XY, Shi MJ, Chen JF, Liao Y, Hu BW, Hireche A. Meng XY, et al. Among authors: shi mj. Dis Markers. 2017;2017:7850708. doi: 10.1155/2017/7850708. Epub 2017 Jun 5. Dis Markers. 2017. PMID: 28655970 Free PMC article. Review.

6

Intrafascial versus interfascial nerve sparing in radical prostatectomy for localized prostate cancer: a systematic review and meta-analysis.

Weng H, Zeng XT, Li S, Meng XY, Shi MJ, He DL, Wang XH. Weng H, et al. Among authors: shi mj. Sci Rep. 2017 Sep 13;7(1):11454. doi: 10.1038/s41598-017-11878-7. Sci Rep. 2017. PMID: 28904361 Free PMC article.

7

[The relationship between tumor recurrence and polymorphisms of hGPX1 and NRAMP1 in superficial bladder cancer patients: a meta-analysis].

Souraka TDM, Shi MJ, Meng XY. Souraka TDM, et al. Among authors: shi mj. Pan Afr Med J. 2017 Aug 10;27:270. doi: 10.11604/pamj.2017.27.270.12282. eCollection 2017. Pan Afr Med J. 2017. PMID: 29187939 Free PMC article. French.

8

The Role of COL5A2 in Patients With Muscle-Invasive Bladder Cancer: A Bioinformatics Analysis of Public Datasets Involving 787 Subjects and 29 Cell Lines.

Meng XY, Shi MJ, Zeng ZH, Chen C, Liu TZ, Wu QJ, Li S, Li S. Meng XY, et al. Among authors: shi mj. Front Oncol. 2019 Jan 15;8:659. doi: 10.3389/fonc.2018.00659. eCollection 2018. Front Oncol. 2019. PMID: 30697528 Free PMC article.

9

APOBEC-mediated Mutagenesis as a Likely Cause of FGFR3 S249C Mutation Over-representation in Bladder Cancer.

Shi MJ, Meng XY, Lamy P, Banday AR, Yang J, Moreno-Vega A, Chen CL, Dyrskjøt L, Bernard-Pierrot I, Prokunina-Olsson L, Radvanyi F. Shi MJ, et al. Eur Urol. 2019 Jul;76(1):9-13. doi: 10.1016/j.eururo.2019.03.032. Epub 2019 Apr 8. Eur Urol. 2019. PMID: 30975452

10

Reply to Alexander Yang, Vincent L. Cannataro, Jeffrey P. Townsend's Letter to the Editor, re: Ming-Jun Shi, Xiang-Yu Meng, Philippe Lamy, et al. APOBEC-mediated Mutagenesis as, a Likely Cause of FGFR3 S249C Mutation Over-representation in Bladder Cancer. Eur Urol 2019, 76:9-13.

Shi MJ, Meng XY, Chen CL, Dyrskjøt L, Radvanyi F, Prokunina-Olsson L, Bernard-Pierrot I. Shi MJ, et al. Eur Urol. 2020 Jan;77(1):e26-e27. doi: 10.1016/j.eururo.2019.08.012. Epub 2019 Sep 5. Eur Urol. 2020. PMID: 31493961 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

122 results

Search Page